UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice

Nutrients, 2021-07, Vol.13 (8), p.2622

2021

Volltextzugriff (PDF)

AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep-Wake Cycles in Rats

Frontiers in pharmacology, 2019-07, Vol.10, p.831-831

2019

Volltextzugriff (PDF)

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

ClinicoEconomics and outcomes research, 2017-01, Vol.9, p.139-147

2017

Volltextzugriff (PDF)

Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity

Experimental brain research, 2014-03, Vol.232 (3), p.935-946

2014

Volltextzugriff (PDF)

Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation

Psychopharmacology, 2013-08, Vol.228 (3), p.439-449

2013

Volltextzugriff (PDF)

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion

Cells (Basel, Switzerland), 2020-02, Vol.9 (3), p.551

2020

Volltextzugriff (PDF)

Adjusted indirect comparisons between generics – bioequivalence and interchangeability

GaBI Journal, 2016-06, Vol.5 (2), p.53-54

2016

Volltextzugriff (PDF)

Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains

BMC neuroscience, 2014-11, Vol.15 (1), p.120-120, Article 120

2014

Volltextzugriff (PDF)

Immunosuppressants increase the levels of natural autoantibodies reactive with glycosaminoglycans in myasthenia gravis

Journal of neuroimmunology, 2014-11, Vol.276 (1), p.224-228

2014

Volltextzugriff (PDF)

Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep-wake cycle

BMC neuroscience, 2019-03, Vol.20 (1), p.14-14, Article 14

2019

Volltextzugriff (PDF)

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis

Arthritis research & therapy, 2008-01, Vol.10 (5), p.R110-R110, Article R110

2008

Volltextzugriff (PDF)

Statistical and regulatory considerations in assessments of interchangeability of biological drug products

The European journal of health economics, 2014-05, Vol.15 (Suppl 1), p.S5-S11

2014

Volltextzugriff (PDF)

Bioequivalence metrics for absorption rates: linearity, specificity, sensitivity

Acta Pharmaceutica Hungarica, 2019-04, Vol.89 (1), p.17-21

2019

Volltextzugriff (PDF)

Partial and full agonism in endomorphin derivatives: Comparison by null and operational model

Peptides (New York, N.Y. : 1980), 2006-06, Vol.27 (6), p.1507-1513

2006

Volltextzugriff (PDF)

Metrics for the Evaluation of Bioequivalence of Modified-Release Formulations

The AAPS journal, 2012-12, Vol.14 (4), p.813-819

2012

Volltextzugriff (PDF)

Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis

Frontiers in immunology, 2022-10, Vol.13, p.960001-960001

2022

Volltextzugriff (PDF)

Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes

PloS one, 2014-11, Vol.9 (11), p.e113662

2014

Volltextzugriff (PDF)

Sample Sizes for Designing Bioequivalence Studies for Highly Variable Drugs

Journal of pharmacy & pharmaceutical sciences, 2011-12, Vol.15 (1), p.73

2011

Volltextzugriff (PDF)

Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls

Frontiers in immunology, 2024-06, Vol.15, p.1397052

2024

Volltextzugriff (PDF)

Next-generation nanomedicines and nanosimilars: EU regulators initiatives relating to the development and evaluation of nanomedicines

Nanomedicine (London, England), 2013-05, Vol.8 (5), p.849-856

2013

Volltextzugriff (PDF)

Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats

BMC genomics, 2018-08, Vol.19 (1), p.580-580, Article 580

2018

Volltextzugriff (PDF)

Determination of bioequivalence for drugs with narrow therapeutic index: reduction of the regulatory burden

Journal of pharmacy & pharmaceutical sciences, 2013-01, Vol.16 (5), p.676

2013

Volltextzugriff (PDF)

Largely Accelerated Arterial Aging in Rheumatoid Arthritis Is Associated With Inflammatory Activity and Smoking in the Early Stage of the Disease

Frontiers in pharmacology, 2020-11, Vol.11, p.523962-523962

2020

Volltextzugriff (PDF)

Do regulatory bioequivalence requirements adequately reflect the therapeutic equivalence of modified-release drug products?

Journal of pharmacy & pharmaceutical sciences, 2010-05, Vol.13 (1), p.107

2010

Volltextzugriff (PDF)

Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization

Journal of pharmacokinetics and pharmacodynamics, 2019-04, Vol.46 (2), p.117-126

2019

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(70)
Tagungsberichte
(4)

Sprache

Englisch
(72)
Ungarisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice

AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep-Wake Cycles in Rats

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity

Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion

Adjusted indirect comparisons between generics – bioequivalence and interchangeability

Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains

Immunosuppressants increase the levels of natural autoantibodies reactive with glycosaminoglycans in myasthenia gravis

Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep-wake cycle

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis

Statistical and regulatory considerations in assessments of interchangeability of biological drug products

Bioequivalence metrics for absorption rates: linearity, specificity, sensitivity

Partial and full agonism in endomorphin derivatives: Comparison by null and operational model

Metrics for the Evaluation of Bioequivalence of Modified-Release Formulations

Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis

Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes

Sample Sizes for Designing Bioequivalence Studies for Highly Variable Drugs

Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls

Next-generation nanomedicines and nanosimilars: EU regulators initiatives relating to the development and evaluation of nanomedicines

Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats

Determination of bioequivalence for drugs with narrow therapeutic index: reduction of the regulatory burden

Largely Accelerated Arterial Aging in Rheumatoid Arthritis Is Associated With Inflammatory Activity and Smoking in the Early Stage of the Disease

Do regulatory bioequivalence requirements adequately reflect the therapeutic equivalence of modified-release drug products?

Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization

Suchergebnisse filtern